A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.
about
Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone TreatmentSystemic therapies for recurrent and/or metastatic salivary gland cancers.Androgen Receptor Signaling in Salivary Gland Cancer.Salivary duct carcinoma: what is already known, and can we improve survival?Systemic therapy in the management of metastatic or advanced salivary gland cancers.Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.The oncogenic role of androgen receptors in promoting the growth of oral squamous cell carcinoma cells.Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors.Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.Management and outcome of salivary duct carcinoma in major salivary glands.Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
P2860
Q34714945-5701A14E-489D-4652-B791-60A140419FC7Q35037277-33237396-98E9-4F9E-B768-5F73348ABD7AQ37118940-2A8622F5-AB65-4803-9780-51E34082395BQ37676074-C4571798-1D6D-4B54-99C5-507943378BF0Q38001863-18D1A93F-58DC-483D-B498-A3FBE556BB23Q38007528-CB02482D-2D0C-47C4-9993-BAEB9D6216E5Q38033677-11476801-FCDB-4D3D-924D-5F9B9038BDA1Q38114366-3B69C3F4-1A71-4F3D-BC06-86532E45EE2CQ38973980-86099B12-FDD5-4C1D-95EF-4750E254E30BQ39831543-96DDD569-53A2-481D-B986-FBBAF14C0A95Q40452694-9EF704DD-1BAC-41EC-8710-7EE110D497AFQ42472950-4DEE5341-6B5F-4C37-9004-2E0B3B60BFFEQ43212008-5592108B-3D90-42E9-A5E4-34BE45D7B057Q45996599-2BC44EA3-F755-46E0-BCF1-148B88A65FBCQ46447217-CD18E596-160C-4686-8C2E-72C995C129E2Q54226554-9EBC168A-7700-46F9-A21D-B484888CB529Q54376069-D81AE939-1B2E-45BD-8A85-284D94569BFE
P2860
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A complete remission with andr ...... arcinoma of the parotid gland.
@en
A complete remission with andr ...... arcinoma of the parotid gland.
@nl
type
label
A complete remission with andr ...... arcinoma of the parotid gland.
@en
A complete remission with andr ...... arcinoma of the parotid gland.
@nl
prefLabel
A complete remission with andr ...... arcinoma of the parotid gland.
@en
A complete remission with andr ...... arcinoma of the parotid gland.
@nl
P50
P356
P1433
P1476
A complete remission with andr ...... carcinoma of the parotid gland
@en
P2093
P304
P356
10.1093/ANNONC/MDG331
P577
2003-08-01T00:00:00Z